BIOC Historical Earnings image   This BIOC historical earnings page last updated 10/4/2022
BIOC Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/23/20220.02B
Q4 20214/6/20220.01B
Q3 202111/15/20210.02B
Q2 20218/16/20210.01B
Q1 20215/12/20210.02B
Q4 20203/29/20210.02B
Q3 202011/12/20200.01B
Q2 20208/12/20200.00B
Q1 20205/13/20200.00B
Q4 20193/25/20200.00B
Q3 201911/13/20190.00B
Q2 20198/12/20190.00B
Q1 20195/8/20190.00B
Q4 20183/28/2019859526
Q3 201811/13/2018761591
Q2 20188/14/2018822238
Q1 20185/15/2018806943
Q4 20173/28/2018995226
Q3 201711/9/20171.11M
Q2 20178/10/20171.28M
Q1 20175/11/20171.68M
Q4 20163/7/20171.29M
Q3 201611/9/20161.05M
Q2 20168/2/2016662860
Q1 20165/12/2016221369
Q4 20153/9/2016218283
Q3 201511/5/2015164856
Q2 20158/10/201576768
Q1 20155/12/2015150000
Q4 20143/9/20150.08M
Q3 201411/13/20140.01M
Q2 20148/8/20140.02M
Q1 20142/6/20140.03M
Q4 201312/31/20130.02M
Q4 20122/5/20130.03M
Q3 201211/12/20120.02M
Q2 20128/8/20120.02M
BIOC Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20225/23/2022-0.160
Q4 20214/6/2022-0.180
Q3 202111/15/20210.030
Q2 20218/16/2021-0.140
Q1 20215/12/20210.190
Q4 20203/29/20210.140
Q3 202011/12/2020-0.430
Q2 20208/12/2020-0.500
Q1 20205/13/2020-1.100
Q4 20193/25/2020-2.000
Q3 201911/13/2019-2.500
Q2 20198/12/2019-3.800
Q1 20195/8/2019-6.100
Q4 20183/28/2019-14.300
Q3 201811/13/2018-24.200
Q2 20188/14/2018-27.000
Q1 20185/15/2018-33.000
Q4 20173/28/2018-54.000
Q3 201711/9/2017-60.000
Q2 20178/10/2017-63.000
Q1 20175/11/2017-63.000
Q4 20163/7/2017-81.000
Q3 201611/9/2016-513.000
Q2 20168/2/2016-180.000
Q1 20165/12/2016-225.000
Q4 20153/9/2016-216.000
Q3 201511/5/2015-216.000
Q2 20158/10/2015-198.000
Q1 20155/12/2015-333.000
Q4 20143/9/2015-783.000
Q3 201411/13/2014-783.000
Q2 20148/8/2014-603.000
Q1 20142/6/2014-1764.000
Q4 201312/31/2013-16533.000
Q4 20122/5/201390.000
Q3 201211/12/2012-603.000
Q2 20128/8/201254.000
Quotes delayed 20 minutes

Email EnvelopeFree BIOC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biocept (BIOC) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BIOL Historical Earnings
BIOR Historical Earnings
BIVI Historical Earnings
BKD Historical Earnings
BLCM Historical Earnings
BLFS Historical Earnings
BLI Historical Earnings
BLPH Historical Earnings
BLUE Historical Earnings
BMEA Historical Earnings
What was the record high BIOC historical earnings result?
In terms of earnings or revenue, what is the best BIOC historical earnings result that Biocept has ever posted, and when?

✔️Accepted answer: Within our data set, the highest BIOC historical earnings result was set in Q4 2012, when Biocept posted results of 90.000/share. The most successful revenue quarter within our data set was Q1 2022 when Biocept reported revenue of 0.02B.

What was the lowest Biocept historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest BIOC has reported, and when?

✔️Accepted answer: Within our data set, the lowest BIOC historical earnings result was set in Q4 2013, when Biocept posted results of -16533.000/share. The smallest revenue quarter within our data set was Q3 2014 when Biocept reported revenue of 0.01M.

On this page we presented the BIOC historical earnings date information for Biocept. Reviewing that BIOC Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2012, when BIOC posted gaap of 90.000/share. Meanwhile the lowest BIOC historical earnings result was in Q4 2013, when BIOC posted gaap of -16533.000/share. Moving to Biocepts historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2022 when BIOC reported 0.02B in revenue, while the smallest revenue quarter was Q3 2014 when BIOC reported 0.01M in revenue.

For self directed investors doing their due diligence on BIOC or any other given stock, their research can benefit from looking into all of the Biocept historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Biocept historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for BIOC. Thanks for visiting, and the next time you need to research BIOC historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: YDKN Historical Stock Prices, ZBH Split History, DGRE Average Annual Return.

 

BIOC Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.